Delivery Order SPE2DB24D2101-SPE2DB24FKFXQ

Award Date 8/15/24
Potential Completion Date 8/16/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024, and a ceiling value of $7,162.27. The award is not associated with a set-aside program. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts by various defense and civilian agencies to provide a...
This is a $1,793.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product OPZELURA 1.5% CREAM 60GM and has a completion date of July 29, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, supporting various defense and civilian agencies. This delivery order is issued under a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a ceiling value of $3,921.56 and a completion date of October 15, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,859.70, is for the supply of OPZELURA 1.5% Cream in 60 gram quantities. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,911.04, is for the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product. The contract has a completion date of December 19, 2024 and is a firm-fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor for this award and the company is registered in the System for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a ceiling value of $12,900.63 and an ultimate completion date of December 3, 2024. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,359.03, is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a performance period through December 16, 2024 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,665.65, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, to support military healthcare programs. The contract is a firm fixed-price, delivery order type, with a period of performance through January 7, 2025. No set-aside designation is mentioned. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,502.37, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a period of performance through December 23, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,395.71 Firm Fixed Price contract is for the supply of OPZELURA 1.5% Cream (60g), a prescription dermatological product. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen is a long-standing supplier to the DLA Troop Support Medical program, providing a wide range of pharmaceutical and medical...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFXQ
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of OPZELURA 1.5% Cream in 60 gram units, with a firm fixed price of $1,917.25 and a completion date of August 16, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous contracts by various defense and civilian agencies to provide a wide range of essential medical commodities, including specialty medications, generic drugs, and medical supplies, to support military treatment facilities, veterans' hospitals, and other federal healthcare providers. This specific delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary vehicle for delivering pharmaceutical and medical products to the federal government.

Generated 11/14/24, 9:24 AM